Compare BCRX & KOS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BCRX | KOS |
|---|---|---|
| Founded | 1986 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 1.7B |
| IPO Year | 1995 | 2011 |
| Metric | BCRX | KOS |
|---|---|---|
| Price | $8.47 | $2.58 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 6 |
| Target Price | ★ $20.82 | $1.91 |
| AVG Volume (30 Days) | 4.2M | ★ 11.0M |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 381.40 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $25,186,000.00 | ★ $1,288,352,000.00 |
| Revenue This Year | N/A | $27.11 |
| Revenue Next Year | $12.55 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $6.00 | $0.84 |
| 52 Week High | $11.22 | $3.34 |
| Indicator | BCRX | KOS |
|---|---|---|
| Relative Strength Index (RSI) | 40.60 | 44.47 |
| Support Level | $8.04 | $2.32 |
| Resistance Level | $10.05 | $3.10 |
| Average True Range (ATR) | 0.32 | 0.14 |
| MACD | -0.00 | -0.04 |
| Stochastic Oscillator | 35.56 | 16.67 |
BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.
Kosmos Energy Ltd is a deepwater exploration and production company focused on meeting the world's growing demand for energy. It has diversified oil and gas production from assets offshore Ghana, Equatorial Guinea, Mauritania, Senegal and the Gulf of America. The Company had operations in four geographic reporting segments: Ghana, Equatorial Guinea, Mauritania/Senegal and the Gulf of America. The majority of revenue is derived from the Ghana segment.